Estrogen-responsive MYC gene expression

Stable Identifier
R-HSA-9011975
Type
Reaction [omitted]
Species
Homo sapiens
Compartment
Locations in the PathwayBrowser
General
SVG |   | PPTX  | SBGN
Click the image above or here to open this reaction in the Pathway Browser
The layout of this reaction may differ from that in the pathway view due to the constraints in pathway layout

MYC gene expression is estrogen-responsive and expression of MYC and CCND1 contribute to the proliferative response stimulated by estrogen treatment (Dubnik et al, 1987; Dubnik et al, 1988; Dubnik and Shu, 1992; Prall et al, 1998). Estrogen-responsive MYC expression appears to depend at least in part on a distal enhancer element 67 kb from the transcriptional start site that contains a half ERE and an AP-1 site (Denardo et al, 2005; Carroll et al, 2006; Wang et al, 2011). Upon estrogen stimulation, these sites are occupied by ESR1 and a JUND:FOSB heterodimer, respectively (Wang et al, 2011). Estrogen-responsive MYC expression also depends on the cohesin complex, as depletion of the RAD21 cohesin subunit abrogates expression (Stedman et al, 2008; Schmidt et al, 2010; McEwan et al, 2011; Antony et al, 2015). Genome-wide studies have shown that RAD21 and ESR1 binding sites overlap in a fraction of estrogen-responsive genes, including MYC (Schmidt et al, 2010). Cohesin may contribute to target gene expression by promoting chromatin looping structures between distal enhancers and the target gene promoters or through other mechanisms that remain to be elucidated (Li et al, 2012; Antony et al, 2015; reviewed Rhodes et al, 2011; Losada, 2014). Overexpression of histone isoform HIST1H2AC in breast cancer has been shown to contribute to MYC gene expression by promoting the formation of activating chromatin loops and facilitating the recruitment of ESR1, EP300 and RNA polymerase II (Su et al, 2014).

Literature References
PubMed ID Title Journal Year
24854081 Cohesin in cancer: chromosome segregation and beyond

Losada, A

Nat. Rev. Cancer 2014
23145106 Cohesin is required for activation of MYC by estradiol

McEwan, MV, Eccles, MR, Horsfield, JA

PLoS ONE 2012
1630819 Mechanism of estrogen activation of c-myc oncogene expression

Dubik, D, Shiu, RP

Oncogene 1992
25542856 Cohesin modulates transcription of estrogen-responsive genes

Antony, J, Dasgupta, T, Rhodes, JM, McEwan, MV, Print, CG, O'Sullivan, JM, Horsfield, JA

Biochim. Biophys. Acta 2015
15514030 Global gene expression analysis of estrogen receptor transcription factor cross talk in breast cancer: identification of estrogen-induced/activator protein-1-dependent genes

DeNardo, DG, Kim, HT, Hilsenbeck, S, Cuba, V, Tsimelzon, A, Brown, PH

Mol. Endocrinol. 2005
21835891 Estrogen induces c-myc gene expression via an upstream enhancer activated by the estrogen receptor and the AP-1 transcription factor

Wang, C, Mayer, JA, Mazumdar, A, Fertuck, K, Kim, H, Brown, M, Brown, PH

Mol. Endocrinol. 2011
3045126 Transcriptional regulation of c-myc oncogene expression by estrogen in hormone-responsive human breast cancer cells

Dubik, D, Shiu, RP

J. Biol. Chem. 1988
18219272 Cohesins localize with CTCF at the KSHV latency control region and at cellular c-myc and H19/Igf2 insulators

Stedman, W, Kang, H, Lin, S, Kissil, JL, Bartolomei, MS, Lieberman, PM

EMBO J. 2008
3677090 Stimulation of c-myc oncogene expression associated with estrogen-induced proliferation of human breast cancer cells

Dubik, D, Dembinski, TC, Shiu, RP

Cancer Res. 1987
24371278 An H2A histone isotype regulates estrogen receptor target genes by mediating enhancer-promoter-3'-UTR interactions in breast cancer cells

Su, CH, Tzeng, TY, Cheng, C, Hsu, MT

Nucleic Acids Res. 2014
20219941 A CTCF-independent role for cohesin in tissue-specific transcription

Schmidt, D, Schwalie, PC, Ross-Innes, CS, Hurtado, A, Brown, GD, Carroll, JS, Flicek, P, Odom, DT

Genome Res. 2010
22265404 Extensive promoter-centered chromatin interactions provide a topological basis for transcription regulation

Li, G, Ruan, X, Auerbach, RK, Sandhu, KS, Zheng, M, Wang, P, Poh, HM, Goh, Y, Lim, J, Zhang, J, Sim, HS, Peh, SQ, Mulawadi, FH, Ong, CT, Orlov, YL, Hong, S, Zhang, Z, Landt, S, Raha, D, Euskirchen, G, Wei, CL, Ge, W, Wang, H, Davis, C, Fisher-Aylor, KI, Mortazavi, A, Gerstein, M, Gingeras, T, Wold, B, Sun, Y, Fullwood, MJ, Cheung, E, Liu, E, Sung, WK, Snyder, M, Ruan, Y

Cell 2012
17013392 Genome-wide analysis of estrogen receptor binding sites

Carroll, JS, Meyer, CA, Song, J, Li, W, Geistlinger, TR, Eeckhoute, J, Brodsky, AS, Keeton, EK, Fertuck, KC, Hall, GF, Wang, Q, Bekiranov, S, Sementchenko, V, Fox, EA, Silver, PA, Gingeras, TR, Liu, XS, Brown, M

Nat. Genet. 2006
21940756 Gene regulation by cohesin in cancer: is the ring an unexpected party to proliferation?

Rhodes, JM, McEwan, M, Horsfield, JA

Mol. Cancer Res. 2011
9671459 c-Myc or cyclin D1 mimics estrogen effects on cyclin E-Cdk2 activation and cell cycle reentry

Prall, OW, Rogan, EM, Musgrove, EA, Watts, CK, Sutherland, RL

Mol. Cell. Biol. 1998
Participants
Participant Of
This event is regulated
Authored
Reviewed
Created